Gastroenterology
Latest News
First Humira biosimilar launches in U.S.
Amgen’s Amjevita will be offered at 5% and 55% below Humira’s list price, but patients may not benefit from the more significant discount.
Feature
Can a nationwide liver paired donation program work?
The program will require a donor (and a support person) to travel to the recipient’s transplant center where the surgery will be performed. A...
From the Journals
Two AI optical diagnosis systems appear clinically comparable for small colorectal polyps
Two computer-aided diagnostic systems meet guidelines to implement cost-saving strategies of leave-in-situ and resect-and-discard, study reports...
From the Journals
Noninvasive liver test may help select asymptomatic candidates for heart failure tests
Heart failure and liver stiffness often coexist due to cardio-hepatic interactions.
Feature
New cancer data spark outcry from patient advocates
The American Cancer Society on Jan. 13 revealed what it called ‘alarming’ news about prostate cancer.
From the Journals
Acute hepatic porphyrias no longer as rare as previously thought
Recent treatment advances have improved the outlook for patients with acute hepatic porphyrias.
Conference Coverage
Gut enzymes fingered in some 5-ASA treatment failures
Patients with inflammatory bowel disease who had three or four specific acetyltransferases in their gut microbiota had a threefold higher risk for...
Conference Coverage
Food additives may exacerbate IBD
Emulsifiers and thickeners added to food in processing may contribute to inflammation and changes in gut microbiota.
Feature
Canadian guidance recommends reducing alcohol consumption
Consuming no drinks per week has benefits.
Conference Coverage
Proof lacking for dual-targeted therapy benefit in IBD
Questions remain unanswered about the effectiveness of combination biologic treatment for inflammatory bowel disease.
From the Journals
Does appendectomy raise the risk for colorectal cancer?
Researchers observed a 73% increase in CRC risk among appendectomy cases, compared with controls over a 20-year follow-up.